Lipoplex size determines lipofection efficiency with or without serum

被引:88
作者
Almofti, MR
Harashima, H
Shinohara, Y
Almofti, A
Li, WH
Kiwada, H [1 ]
机构
[1] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 7708505, Japan
[2] Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan
[3] Univ Tokushima, Sch Dent, Tokushima 7708505, Japan
关键词
cationic liposomes; DNA; lipofection; fusion; uptake;
D O I
10.1080/09687680210035104
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to identify factors affecting cationic liposome-mediated gene transfer, the relationships were examined among cationic liposome/DNA complex (lipoplex)-cell interactions, lipoplex size and lipoplex-mediated transfection (lipofection) efficiency. It was found that lipofection efficiency was determined mainly by lipoplex size, but not by the extent of lipoplex-cell interactions including binding, uptake or fusion. In addition, it was found that serum affected mainly lipoplex size, but not lipoplex-cell interactions, which effect was the major reason behind the inhibitory effect of serum on lipofection efficiency. It was concluded that, in the presence or absence of serum, lipoplex size is a major factor determining lipofection efficiency. Moreover, in the presence or absence of serum, lipoplex size was found to affect lipofection efficiency by controlling the size of the intracellular vesicles containing lipoplexes after internalization, but not by affecting lipoplex-cell interactions. In addition, large lipoplex particles showed, in general, higher lipofection efficiency than small particles. These results imply that, by controlling lipoplex size, an efficient lipid delivery system may be achieved for in vitro and in vivo gene therapy.
引用
收藏
页码:35 / 43
页数:9
相关论文
共 30 条
[1]   LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS [J].
CAPLEN, NJ ;
ALTON, EWFW ;
MIDDLETON, PG ;
DORIN, JR ;
STEVENSON, BJ ;
GAO, X ;
DURHAM, SR ;
JEFFERY, PK ;
HODSON, ME ;
COUTELLE, C ;
HUANG, L ;
PORTEOUS, DJ ;
WILLIAMSON, R ;
GEDDES, DM .
NATURE MEDICINE, 1995, 1 (01) :39-46
[2]   Structure and function of lipid-DNA complexes for gene delivery [J].
Chesnoy, S ;
Huang, L .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2000, 29 :27-47
[3]   TRANSFER OF GENES TO HUMANS - EARLY LESSONS AND OBSTACLES TO SUCCESS [J].
CRYSTAL, RG .
SCIENCE, 1995, 270 (5235) :404-410
[4]   INHIBITION OF PROTEIN-KINASE C-ALPHA EXPRESSION IN MICE AFTER SYSTEMIC ADMINISTRATION OF PHOSPHOROTHIOATE ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
DEAN, NM ;
MCKAY, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11762-11766
[5]   Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes [J].
Escriou, V ;
Ciolina, C ;
Lacroix, F ;
Byk, G ;
Scherman, D ;
Wils, P .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1368 (02) :276-288
[6]   Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivo [J].
Fasbender, A ;
Marshall, J ;
Moninger, TO ;
Grunst, T ;
Cheng, S ;
Welsh, MJ .
GENE THERAPY, 1997, 4 (07) :716-725
[7]   Improved cationic lipid formulations for in vivo gene therapy [J].
Felgner, PL ;
Tsai, YJ ;
Sukhu, L ;
Wheeler, CJ ;
Manthorpe, M ;
Marshall, J ;
Cheng, SH .
DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 :126-139
[8]   LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE [J].
FELGNER, PL ;
GADEK, TR ;
HOLM, M ;
ROMAN, R ;
CHAN, HW ;
WENZ, M ;
NORTHROP, JP ;
RINGOLD, GM ;
DANIELSEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7413-7417
[9]   MODE OF FORMATION AND STRUCTURAL FEATURES OF DNA CATIONIC LIPOSOME COMPLEXES USED FOR TRANSFECTION [J].
GERSHON, H ;
GHIRLANDO, R ;
GUTTMAN, SB ;
MINSKY, A .
BIOCHEMISTRY, 1993, 32 (28) :7143-7151
[10]  
HUANG L, 1999, NONVIRAL VECTORS GEN, P4